Annual jab for HIV protection passes trial hurdle
Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.
Join our subscribers list to get the latest news, updates and special offers directly in your inbox
hello@uk4mag.co.uk Mar 7, 2025 0 12
hello@uk4mag.co.uk Mar 20, 2025 0 11
hello@uk4mag.co.uk May 1, 2025 0 9
hello@uk4mag.co.uk Nov 3, 2023 0 7
hello@uk4mag.co.uk Mar 20, 2025 0 74
hello@uk4mag.co.uk Nov 4, 2025 0 15
Companies are offering tech they say can accurately test the health of batteries...
hello@uk4mag.co.uk Nov 4, 2025 0 14
The Suzy Lamplugh Trust commissioned polling to assess workers’ experiences and...
hello@uk4mag.co.uk Nov 4, 2025 0 18
The two men face federal charges of planning a terrorist attack inspired by the...
hello@uk4mag.co.uk Nov 4, 2025 0 18
Criminal inquiries pit the Miller family’s safety concerns against the First Amendment...
hello@uk4mag.co.uk Nov 4, 2025 0 15
The oil giant reported third quarter underlying replacement cost profits of 2.21...
hello@uk4mag.co.uk Nov 4, 2025 0 16
More people are turning to AI for help with their relationships, but is that a good...
hello@uk4mag.co.uk Nov 4, 2025 0 17
Gone are the days when facelifts were for the ageing wealthy. Now younger people...
hello@uk4mag.co.uk Nov 4, 2025 0 20
At the Durango, Colo., police chief’s request, Colorado law enforcement will investigate...
hello@uk4mag.co.uk Nov 4, 2025 0 20
The Conservative leader said keeping donors on side ‘actually took quite a lot of...
hello@uk4mag.co.uk Nov 4, 2025 0 15
Manufacturers also pointed towards subdued UK demand amid caution ahead of the autumn...
